Skip to main content

Prices of biotechnology and pharmaceutical stocks in Canada are all below their 52-week highs, but the falls are generally not as severe as those for hi-tech stocks. With the proposed buyout of BioChem Pharma, investor interest may turn to this sector. Here are the largest companies in the group by market capitalization together with their most recent year's revenue, if any, and their price-to-earnings ratios for those stocks with earnings.

Market cap, Dec. 8
Price fall from
Revenue
Company
($million)
52-week high*
P/E
$million
Biovail            $7,403               -9%         -       $262
QLT                 5,017              -37         310        26
BioChem Pharma      4,051              -13          13       276
MDS                 3,737              -14          35     1,192
Angiotech             959              -54          -          4
Patheon               692               -8          60       127
AnorMed               507              -18          -          0
Biomira               505              -65          -          3
Hemosol               489              -45          -          2
Axcan Pharma          476              -19          48       129
Cangene               455              -35          64        47
Vasogen               402              -51          -          0
Theratechnologies     383              -28          -          2
Dimethaid             378              -42          -          1
Stressgen             355              -47          -          3
Aeterna               300              -51          42         6
Canadian Medical      296              -35           9       130
NPS Allelix           289              -12          -          0
Dynacare              267               -3          -          0
Micrologix            237              -56          -          0
Oncolytics            225              -38          -          0

TSE Biotechnology

/Pharmaceutical Index   0              -10

- *Note: Price drop is to yesterday's close. Revenue is for most recent financial year. Source: Bloomberg Financial Services Alexandra Eadie is a statistician at Report on Business ( aeadie@globeandmail.ca)